REPRINTED | HALF YEAR ECONOMIC OBSERVATION | BEIJING E-TOWN APPROVED CLINICAL CLASS I NEW DRUGS ACCOUNT FOR 57% OF THE CITY'S TOTAL
GOOD NEWS | IMMUNOTECH BIOPHARM-B (06978. HK) ZHANG YONGHUA HAS BEEN AWARDED THE HONORARY TITLE OF OUTSTANDING COMMUNIST PARTY MEMBER IN BEIJING ECONOMIC DEVELOPMENT AERA
THE PARTY BRANCH OF IMMUNOTECH BIOPHARM LTD-B (06978. HK) WAS AWARDED THE HONOR OF FOUR-STAR PARTY ORGANIZATION IN THE ECONOMIC DEVELOPMENT ZONE
GOOD NEWS | YONGTAI RUIKE HAS SUCCESSFULLY OBTAINED THE NATIONAL "HIGH-TECH ENTERPRISE" CERTIFICATION!
IMMUNOTECH BIOPHARM LTD-B (06978. HK) and Corning Incorporated Jointly Expanding Product Commercialization Cooperation
HEAVYWEIGHT AWARD | IMMUNOTECH BIOPHARM LTD-B (06978. HK) WAS AWARDED THE "OUTSTANDING INNOVATION ENTERPRISE" IN BEIJING ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE IN 2023
Clinical Progress | IMMUNOTECH BIOPHARM Ltd-B (06978. HK) aT19 Injection Successfully received an approval of Clinical Trial
Good News | Zhang Yonghua, Director of NGMC Product Department at Immunotech Biophara Ltd-B (06978. HK) , elected as "2023 Yizhuang Role Model"
Page up
1
2
...
6
Page down